News
02-12-2013, 02:26 AM
Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy...
More... (http://www.medicalnewstoday.com/releases/256146.php)
More... (http://www.medicalnewstoday.com/releases/256146.php)